Illumina Launches Personal Genome-Sequencing Service Using Genome Analyzer II
June 16, 2009
Illumina Launches Personal Genome-Sequencing Service Using Genome Analyzer II
The company will offer its service for $48,000 through a physician, and will conduct the sequencing at its newly CLIA-certified laboratory in San Diego. Illumina has teamed up with 23andMe, Navigenics, Decode Genetics, and Knome to interpret the data.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina's New DTC Sequencing Service Addresses Ethical Quandary by Requiring Prescription
June 10, 2009 / Pharmacogenomics Reporter - FDA Warns DTC Genomics Firms that Genetic Tests are Not LDTs, May Need Clearance or Approval
June 16, 2010 / Pharmacogenomics Reporter - In Wake of Myriad Decision, Some Debate Licensing Models for Gene Patents, While Some Question Value
April 28, 2010 / Pharmacogenomics Reporter - Illumina Delivers Personal Genome Sequencing Results to First Consumer: Amadeus Capital's Hauser
September 2, 2009 / Pharmacogenomics Reporter - Illumina Partners with DTC Genomics Firms to Offer Whole Genome Sequencing for $48K
June 11, 2009 / GenomeWeb Daily News